Cancer feature: cnaBRCA8

ACRBP ACSM4 ADIPOR2 AKAP3 ANO2 ATN1 C12orf4 C12orf5 C12orf57 C1R C1RL C1S CACNA1C CACNA2D4 CCND2 CD163 CD163L1 CD27 CD4 CD9 CDCA3 CHD4 CLSTN3 COPS7A DCP1B DYRK4 EFCAB4B EMG1 ENO2 ERC1 FBXL14 FGF23 FGF6 FKBP4 FOXM1 GALNT8 GAPDH GNB3 GPR162 IFFO1 ING4 ITFG2 KCNA1 KCNA5 KCNA6 LAG3 LPAR5 LPCAT3 LRRC23 LRTM2 LTBR MLF2 MRPL51 NCAPD2 NDUFA9 NOP2 NRIP2 NTF3 PARP11 PEX5 PHB2 PIANP PLEKHG6 PRMT8 PTMS PTPN6 RAD51AP1 RAD52 RBP5 RHNO1 RP11-234B24.6 RP11-500M8.7 SCNN1A SPSB2 TAPBPL TEAD4 TNFRSF1A TPI1 TSPAN9 TULP3 USP5 VAMP1 VWF WNK1 WNT5B ZNF384

Known Driver Genes: None

Copy number alternation: gain

Elephantin

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer